IP Library Granted Patent US 8,110,678
Granted Patent B2
US 8,110,678 · App. 11/746,704 · Granted Feb 7, 2012

Antibiotic-bound poly(caprolactone) polymer

Assignee: University of South Florida
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,678
App. No.
11/746,704
Granted
Feb 7, 2012
Kind
B2
Abstract

This invention is the design and synthesis of a caprolactone monomer which bears a pendant protected carboxyl group. This monomer has been copolymerized with caprolactone in varying ratios. After polymerization, the protecting group can be removed and an antibiotic can be attached as a new pendant group. The bioactivity of the antibiotic-bound poly(caprolactone) polymer is described.

Claims (16)

1. A compound consisting of:

a caprolactone ring;

a spacer consisting of a methylene group, and a carbonyl group at a terminus of the methylene group, wherein the methylene group at the other terminus is attached to the C-4 position on the caprolactone ring; and

a 2-azetidinone, wherein an alkylthio is attached to the N-1 position, a hydroxyl group is attached to the C-3 position and an aryl ring is attached to the C-4 position, the C-3 hydroxyl group is joined to the spacer by removing the hydrogen atom of the hydroxyl group.

2. The compound represented by the formula:

3. The compound represented by the formula:

4. The compound represented by the formula:

5. A method of producing a compound comprising:

providing

a caprolactone ring;

a spacer, consisting of one methylene group, and a carbonyloxy group at one terminus of the methylene groups, wherein the methylene group at the other terminus is attached to the C-4 position of the caprolactone ring;

a protecting group, attached to the carbonyloxy group on the spacer;

a 2-azetidinone, wherein an alkylthio is attached to the N-1 position, a hydroxyl group is attached to the C-3 position and an aryl ring is attached to the C-4 position;

removing the protecting group from the spacer attached to the caprolactone;

forming an ester between the hydroxyl group on the 2-azetidinone and the carbonyloxy group on the spacer attached to the caprolactone.

6. The method of claim 5 wherein the protecting group is selected from the group consisting of a benzyl and a tert-butyl.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 6, 2012
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028003/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2007
From: TUROS, EDWARD; LESLIE, MICHELLE
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 019636/0709 →
Continuity (2)
Provisional Application 60747061 · May 11, 2006
Related Publication 20070265243A1 · Nov 15, 2007